CTQ, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to ASX. 3 insiders have disclosed 4 filings since 18 October 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of CTQ for at least a year.
With 4 filings in twelve months, the company is more active than the median of 3 filings across the 2,222 companies we follow on the same exchange.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2024 · cache
4 of 4 declarations
CTQ is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market. It focuses on developing innovative solutions to enhance healthcare.
Purchases our model currently ranks for the recommendations list.
All recommendations